All of the following are features of MEN II a, except:
**Core Concept**
Multiple Endocrine Neoplasia type II A (MEN II A) is a rare genetic disorder characterized by the occurrence of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism due to mutations in the RET proto-oncogene. This condition is part of a spectrum of MEN disorders that also include MEN I and MEN II B.
**Why the Correct Answer is Right**
MEN II A is typically associated with a triad of medullary thyroid carcinoma, pheochromocytoma, and primary hyperparathyroidism. The condition is caused by mutations in the RET proto-oncogene, which encodes a receptor tyrosine kinase involved in cell signaling pathways. The activation of this gene leads to the development of the characteristic tumors. Pheochromocytomas, in particular, are often bilateral and can cause symptoms due to excessive catecholamine production.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because MEN II A is indeed associated with medullary thyroid carcinoma, which is a key feature of the condition.
**Option B:** This option is incorrect because primary hyperparathyroidism is a feature of MEN II A, although it is less common than in MEN I. However, the presence of hyperparathyroidism does not exclude the diagnosis of MEN II A.
**Option C:** This option is incorrect because pheochromocytomas are a characteristic feature of MEN II A, although they are more commonly associated with MEN II B. However, the presence of pheochromocytomas in MEN II A does not exclude the diagnosis.
**Clinical Pearl / High-Yield Fact**
MEN II A is caused by mutations in the RET proto-oncogene, which is a key gene involved in cell signaling pathways. This knowledge can help clinicians identify patients at risk of developing this condition and provide timely management and screening.
**Correct Answer:** D